Atlas Trials

A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia

Clinical trial NCT04261270 · UNKNOWN

Trial details

NCT number
NCT04261270
Sponsor
Tongji Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
2019-nCoV Pneumonia
Start date
2020-02-01
Primary completion
2020-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.